People with cardiovascular risk Several GLP-1 drugs, including liraglutide, semaglutide, and dulaglutide, have demonstrated benefits in reducing the risk of heart attack, stroke, and cardiovascular death in people with Type 2 diabetes and existing heart disease
Because many individuals request GLP-1s due to a focus on body weight, other key components in the obesity management journey must be considered and discussed before initiating these therapies
We help you set realistic goals, celebrate your successes, and stay committed to your health journey, even in the face of setbacks
Licensed professionals make medical decisions based on the regulations of states and federal laws
We want WCHE to be not only a beacon for health equity done right in the areas Wellstar serves in the state of Georgia, Lockamy-Kassim said
doi: 10.1016/j.diabres.2021.109003